story of the week
Time to Relapse After Tildrakizumab Withdrawal in Patients With Moderate-to-Severe Psoriasis Who Were Responders at Week 28
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Time to Relapse After Tildrakizumab Withdrawal in Patients With Moderate-to-Severe Psoriasis Who Were Responders at Week 28: Post Hoc Analysis Through 64 Weeks From reSURFACE 1 Trial
J Eur Acad Dermatol Venereol 2020 Sep 26;[EPub Ahead of Print], RB Warren, JM Carrascosa, E Fumero, A Schoenenberger, MG Lebwohl, JC Szepietowski, K ReichFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.